Search

everythinglearnresearchcommunity

for

Search:↓

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Some blood thinners and blood pressure medicines can cause hair loss, which usually starts 1 to 6 months after beginning the medication.

Abusing steroids can damage your heart, muscles, reproductive system, liver, skin, and brain, and may increase the risk of Alzheimer's disease.

Low-dose oral minoxidil might help with hair loss during chemotherapy, but more research is needed.

Test thyroid function in all obese patients and prioritize weight loss for hormonal balance.

Targeting endolysosomes may help treat COVID-19.

Myhre syndrome symptoms worsen over time, with specific genetic variants affecting severity.

Older men with low levels of a testosterone byproduct had a higher chance of developing an irregular heartbeat.

Combination therapies for androgenetic alopecia work best but can have significant side effects and costs.

More knowledge about the risks of performance-enhancing agents leads to less use in north-western Saudi Arabia.

The UD-PrOZA program successfully diagnosed 18% of adult patients with rare diseases, often using genetic testing.

Targeting thyroid hormone receptor α in liver cells may help treat liver fibrosis.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

Hair follicles have a more inactive cell cycle than other skin cells, which may help develop targeted therapies for skin diseases and cancer.

New-onset fibromyalgia after COVID-19 is poorly understood and needs more research.

Drug repositioning is a promising way to quickly develop new treatments, especially for rare diseases.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

Many pediatric epilepsy patients experience preventable severe adverse drug reactions, especially with certain medications and risk factors.

The conclusion is that a team of skin doctors and psychiatrists is needed to better treat patients with mind-skin disorders.

A man wrongly believed he had parasites, showing that delusional infestation can affect men and is often linked with other psychiatric issues, but can be treated with antipsychotics.

Enzymes play crucial roles in metabolism, health, and disease management.

Polydopamine is a safe, effective, and permanent hair dye that turns gray hair black in one hour.

Electrospun nanofiber membranes are promising for non-invasive medical uses like tissue repair and health monitoring.

Sirtuin 1 could be a potential drug target for treating hypertrophic scars.

The conclusion is that genetic testing is important for diagnosing and treating various genetic hair disorders.

Triboelectric nanogenerators can power wearable medical devices for long-term self-treatment and monitoring.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

High-dose oral minoxidil in children can cause increased hair growth, especially on the face.

Patients and oncologists prioritize survival benefits, while payers focus on treatment costs.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.